Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Muscle Invasive Bladder Cancer
NCT07578233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2026-05-11
Summary
This research aimed to determine how accurately multiparametric magnetic resonance imaging (MRI), when interpreted using the VI-RADS scoring system, can distinguish between invasive and non-invasive bladder cancer.
Conditions
- Multiparametric
- Magnetic Resonance Imaging
- Validation
- Vesical Imaging Reporting and Data System (VI-RADS)
- Muscle Invasive Bladder Cancer
Interventions
- OTHER
-
Magnetic resonance imaging
All patients underwent magnetic resonance imaging evaluation.
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2025-03-01
- Completion
- 2025-03-01
Countries
- Egypt
Study Locations
More Related Trials
-
mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer
NCT06335667 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location
NCT06337591 ·Status: COMPLETED
-
Radiogenomics of Muscle Invasive Bladder Cancer
NCT04806334 ·Status: TERMINATED ·Phase: NA
-
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
NCT06775977 ·Status: RECRUITING
-
Clinical Utility of VI-RADS in Diagnosis of MIBC
NCT05097404 ·Status: UNKNOWN
-
Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses
NCT05097105 ·Status: UNKNOWN
-
The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.
NCT04603612 ·Status: COMPLETED ·Phase: NA
-
Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making
NCT04533672 ·Status: COMPLETED ·Phase: NA
-
Use of Multiphoton Microscopy in the Diagnosis of Cancer
NCT00652210 ·Status: COMPLETED ·Phase: PHASE1
-
A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer
NCT06735287 ·Status: RECRUITING ·Phase: NA
-
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
NCT03591367 ·Status: COMPLETED ·Phase: NA
-
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
NCT03148158 ·Status: UNKNOWN
-
Medical Imaging in Bladder Tumors by MRI
NCT06033040 ·Status: RECRUITING
-
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
NCT04369560 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.
NCT07259798 ·Status: COMPLETED ·Phase: NA
-
External Beam Radiotherapy for Muscle Invasive Bladder Cancer
NCT02748200 ·Status: COMPLETED ·Phase: PHASE1
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
NCT06991868 ·Status: RECRUITING
-
Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.
NCT04647981 ·Status: COMPLETED
-
A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection
NCT07142200 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation
NCT05912205 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC
NCT04897763 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mapping 3D Bladder
NCT05260788 ·Status: WITHDRAWN
-
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
NCT07525349 ·Status: NOT_YET_RECRUITING
-
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
NCT03715660 ·Status: COMPLETED ·Phase: NA